Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes

European Journal of Immunology

Volumn 28, Issue 1, 1998, Pages 114-121

  Vecchiarelli, Anna ^a   Monari, Claudia ^a   Retini, Cinzia ^a   Pietrella, Donatella ^a   Palazzetti, Barbara ^a   Pitzurra, Lucia ^a   Casadevall, Arturo ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

B7 1; Cc stimulatory molecule; Cryptococcus neoformans; Monocyte

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; HUMAN; HUMAN CELL; KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; POLYSACCHARIDES; SIGNAL TRANSDUCTION;

EID: 0031975647     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199801)28:01<114::AID-IMMU114>3.0.CO;2-B     Document Type: Article

References (35)

1. Murphy, T. F. and Sethi, S., Bacterial infection in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1992. 146: 1067-1083.
2. Busse, W. W., Pathogenesis and sequelae of respiratory infection. Rev. Infect. Dis. 1991. 13 (Suppl. 6): 8477-8485.
3. Miller, M. F. and Mitchell, T. G., Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect. Immun. 1991. 59: 24-28.
4. Murphy, J. W., Hidorre, M. R. and Wong, S. C., Direct interactions of human lymphocytes with the yeast-like organism Cryptococcus neoformans. J. Clin. Invest. 1993. 91: 1553-1566.
5. Lee, S. C., Casadevall, A. and Dickson, D. W., Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis. Am. J. Pathol. 1996. 148: 1267-1274.
6. Kozel, T. R. and Gotschlich, E., The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast macrophages. J. Immunol. 1982. 129: 1675-1680.
7. Cross, C. E. and Bancroft, G. J., Ingestion of acapsular Cryptococcus neoformans occurs via mannose and β-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect. Immun. 1995. 63: 2604-2611.
8. Vecchiarelli, A., Dottorini, M., Pietrella, D., Monari, C., Retini, C., Todisco, T. and Bistoni, F., Role of alveolar macrophages as antigen presenting cells in Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol. 1994. 11: 130-137.
9. Vecchiarelli, A., Pietrella, D., Dottorini, M., Monari, C., Retini, C., Todisco, T. and Bistoni, F., Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin. Exp. Immunol. 1995. 98: 217-223.
10. Retini, C., Vecchiarelli, A., Monari, C., Tascini, C., Bistoni, F. and Kozel, T. R., Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect. Immun. 1996. 64: 2897-2903.
11. Dong, Z. M. and Murphy, J. W., Intravascular cryptococcal culture filtrate (CNEF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect. Immun. 1995. 63: 770-778.
12. Drouhet, E. and Secretain, G., Inhibition de la migration leucoytaire in vitro par un polyoside capsulare de torulopsis (Cryptococcus) neoformans. Ann. Inst. Pasteur 1951. 81: 674.
13. Dong, Z. M. and Murphy, J. W., Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis receptor loss from the surface of human neutrophils. J. Clin. Invest. 1996. 97: 689-698.
14. Vecchiarelli, A., Retini, C., Monari, C., Tascini, C., Bistoni, F. and Kozel, T. R., Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect. Immun. 1996. 64: 2846-2849.
15. Vecchiarelli, A., Retini, C., Pietrella, D., Monari, C., Tascini, C., Beccari, T. and Kozel, T. R., Down regulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1β secretion from human monocytes. Infect. Immun. 1995. 63: 2919-2923.
16. Jenkins, M. K. and Johnson, J. G., Molecules involved in T-cell costimulation. Curr. Opin. Immunol. 1993. 5: 361-367.
17. Freeman, G. J., Freedman, A. S., Segil, J. M., Lee, G., Whitman, J. F. and Nadler, L. M., B7, a new member of the lg superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 1989. 143: 2714-2722.
18. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C. and Nadler, L. M., B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 1991. 88: 6575-6579.
19. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L. and Somoza, C-, B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993. 366: 76-79.
20. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Hathcock, K. S., Laszlo, G., McKnight, A. J., Kim, J., Du, L. and Lombard, D. B., Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 1993. 262: 907-909.
21. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, Jr., V. A., Lombard, L. A., Gray, G. S. and Nadler, L. M., Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993. 262: 909-911.
22. Engel, P., Gribben, J. G., Freeman, G. J., Zhou, L. J., Nozawa, Y., Abe, M., Nadler, L. M., Wakasa, H. and Tedder, T. F., The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes in the CF86 differentiation antigen. Blood 1994. 84: 1402-1407.
23. June, C. H., Bluestone, J. A., Nadler, L. M. and Thompson, C. B., The B7 and CD28 receptor families. Immunol. Today 1994. 15: 321-331.
24. Freedman, A. S., Freeman, G. J., Rhynhart, K. and Nadler, L. M., Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol. 1991. 137: 429-437.
25. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. M. and Allison, J. P., CD28-mediated signaling Costimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992. 356: 607-609.
26. Jenkins, M. K. and Schwartz, R. H., Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 1987. 165: 302-319.
27. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G. and Nadler, L. M., Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA 1993. 90: 6586-6590.
28. Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P. and Modes, R. J., Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 1994. 183: 631-640.
29. Attal, H. C., Grover, S., Bansal, M. P., Chaubey, B. S. and Joglekar, V. K., Capsule deficient Cryptococcus neoformans an unusual clinical presentation. J. Assoc. Physicians India. 1983. 31: 49-51.
30. Farmer, S. G. and Komorowski, R. A., Histologic response to capsule-deficient Cryptococcus neoformans. Arch. Pathol. 1973. 96: 383-387.
31. Gutierrez, F., Fu, Y. S. and Lurie, H. I., Cryptococcosis histologically resembling histoplasmosis. A light and electron microscopical study. Arch. Pathol. 1975. 99: 347-352.
32. Kagaya, K., Yamada, T., Miyakawa, Y., Fukazawa, Y. and Saito, S., Characterization of pathogenic constituents of Cryptococcus neoformans strains. Microbiol. Immunol. 1985. 29: 517-532.
33. Shadomy, H. J. and Lurie, H. I., Histopathological observations in experiment cryptococcosis by a hypha-producing strain of Cryptococcus neoformans (Coward strain) in mice. Sabouraudia 1971. 9: 6-9.
34. Feldmesser, M. and Casadevall, A., Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J. Immunol. 1997. 158: 790-799.
35. Casadevall, A., Mukherjee, J., Devi, S. J. N., Schneerson, R., Robbins, J. B. and Scharff, M. D., Antibodies elicited by a Cryptococcus neoformans glucuronoxylomannan-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J. Infect. Dis. 1992. 65: 1086-1093.